Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for Cognitive Deficits and Smoking in Schizophrenia
NCT00802919Phase 4Completed
- Sponsor
- Nathan S. Kline Institute for Psychiatric Research
- Start
- Sep 2008
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of varenicline in nicotine dependence, schizophrenia, sponsored by Nathan S. Kline Institute for Psychiatric Research. Started Sep 2008; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependenceschizophrenia
Beyond the preview
Go deeper on NCT00802919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00802919.